179 studies found for:    Open Studies | "Skin Diseases, Infectious"
Show Display Options
Rank Status Study
1 Recruiting Human Immunity Against Staphylococcus Aureus Skin Infection
Condition: Staphylococcus Aureus Skin Infection
Intervention: Other: Killed Bacteria
2 Recruiting Clinical and Economic Outcomes of Ceftaroline Fosamil for ABSSSI Documented or at Risk of MRSA
Conditions: Skin Diseases, Infectious;   Staphylococcal Skin Infections
Interventions: Drug: Ceftaroline;   Drug: Vancomycin
3 Recruiting Skin and Soft Tissue Infection (SSTI) Study
Conditions: Skin Diseases, Infectious;   Soft Tissue Infections
Interventions: Drug: Provodine;   Procedure: Incision and Drainage
4 Recruiting Study of Tedizolid Phosphate in Adolescents With Complicated Skin and Soft Tissue Infection (cSSTI) (MK-1986-012)
Conditions: Skin Diseases, Infectious;   Skin Diseases, Bacterial
Interventions: Drug: Tedizolid Phophate 200 mg, IV and/or oral for 6 days;   Drug: Antibiotic comparator
5 Recruiting Safety and Efficacy of BAY1192631 in Japanese Patients With Methicillin-resistant Staphylococcus Aureus (MRSA) Infections
Condition: Skin Diseases, Infectious
Interventions: Drug: Tedizolid(BAY1192631);   Drug: Linezolid
6 Recruiting Patient-Centered Comparative Effectiveness Research (CER) Study of Home-based Interventions to Prevent CA-MRSA Infection Recurrence
Conditions: Methicillin-Resistant Staphylococcus Aureus;   Recurrence;   Staphylococcal Skin Infections;   Antibiotic Resistance
Interventions: Drug: 2% mupirocin ointment;   Other: Chlorhexidine wash;   Behavioral: Hygiene protocol
7 Not yet recruiting Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA
Conditions: Methicillin-Resistant Staphylococcus Aureus;   Bacterial Infections;   Staphylococcal Skin Infections
Interventions: Drug: Dalbavancin single dose;   Drug: Dalbavancin two dose;   Drug: Comparator
8 Recruiting Efficacy and Safety of Silk Fibroin With Bioactive Coating Layer Dressing
Conditions: Late Complication From Skin Graft;   Infection of Skin Donor Site;   Impaired Wound Healing;   Pain, Intractable
Interventions: Device: Silk fibroin with bioactive coating layer dressing;   Device: Bactigras wound dressing
9 Recruiting Comparing the Intravenous Treatment of Skin Infections in Children, Home Versus Hospital
Condition: Cellulitis
Interventions: Other: Home;   Other: Ward;   Drug: ceftriaxone;   Drug: flucloxacillin
10 Recruiting Asymptomatic Colonization With S. Aureus After Therapy With Linezolid or Clindamycin for Acute Skin Infections
Conditions: Skin Diseases, Bacterial;   Abscess
Interventions: Biological: Linezolid;   Biological: Clindamycin
11 Recruiting Use of Corticosteroids in Children With Cellulitis
Condition: Cellulitis
Interventions: Drug: Dexamethasone;   Drug: Normal Saline
12 Not yet recruiting Safety and Efficacy of NAFT900 in Children With Tinea Capitis
Condition: Tinea Capitis
Interventions: Drug: Naftifine hydrochloride foam, 3%;   Drug: Vehicle
13 Not yet recruiting Effectiveness Study of Ketoconazole and Betamethasone to Treat Fungal Infection and Dermatophytosis
Condition: Tinea
Interventions: Drug: Ketoconazole + betamethasone dipropionate;   Drug: Clotrimazole + Dexamethasone acetate
14 Recruiting Use of a Single Dose of Oral Prednisone in the Treatment of Cellulitis
Condition: Cellulitis
Interventions: Drug: Prednisone;   Drug: Placebo
15 Recruiting Duration of ANtibiotic Therapy for CEllulitis
Conditions: Cellulitis;   Erysipelas
Interventions: Drug: Flucloxacillin;   Drug: Placebo (for flucloxacillin)
16 Recruiting Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Conditions: Infection;   Hypertension;   Pain;   Reflux;   Edema;   Hyperlipidemia;   Hypotension;   Hypercholesterolemia;   Sedation;   Anxiolysis;   Benzodiazepine Withdrawal;   Bipolar Disorder;   Autistic Disorder;   Schizophrenia;   Influenza Treatment or Prophylaxis;   Acute Decompensated Heart Failure;   Stable Angina;   Life-threatening Fungal Infections;   Nosocomial Pneumonia;   Community Acquired Pneumonia;   Acute Bacterial Exacerbation of Chronic Bronchitis;   Complicated Skin and Skin Structure Infections;   Uncomplicated Skin and Skin Structure Infections;   Chronic Bacterial Prostatitis;   Complicated Urinary Tract Infections;   Acute Pyelonephritis;   Uncomplicated Urinary Tract Infections;   Inhalational Anthrax (Post-Exposure);   Infantile Hemangioma;   Withdrawal;   Inflammation;   Bacterial Septicemia;   Cytomegalovirus Retinitis;   Herpes Simplex Virus;   Adenovirus;   Brain Swelling;   Airway Swelling;   Adrenal Insufficiency;   Anxiety;   Nausea;   Vomiting;   Convulsions;   Muscle Spasms;   Seizures;   Epilepsy;   Bartonellosis;   Brucellosis;   Cholera;   Plague;   Psittacosis;   Q Fever;   Relapsing Fever;   Rocky Mountain Spotted Fever;   Trachoma;   Tularemia;   Typhus Fever;   Bronchospasm;   Cardiac Arrest;   Hypersensitivity Reaction;   Cyanide Poisoning;   Acute Bacterial Sinusitis;   Bacterial Meningitis;   Sepsis;   Gastroparesis;   Opioid Addiction;   Migraines;   Headaches
Intervention: Drug: The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:
17 Unknown  Once a Day Topical Treatment for Athlete's Foot Fungus Inbetween the Toes in Males and Females
Conditions: Tinea Pedis;   Athlete's Foot;   Foot Fungus;   Ringworm
Intervention: Drug: Sertaconazole nitrate cream 2%
18 Not yet recruiting Evaluating the Effect of Isotretinoin in Regulatory T-cell Function in Adverse Cutaneous Drug Eruptions (ACDEs): A Pilot Study
Condition: Toxic Epidermal Necrolysis
Interventions: Drug: Isotretinoin;   Other: Placebo
19 Recruiting Azithromycin - Ivermectin Mass Drug Administration for Skin Disease
Conditions: Scabies;   Yaws;   Impetigo
Interventions: Drug: Ivermectin;   Drug: Azithromycin;   Drug: Permethrin
20 Not yet recruiting G-CSF in the Treatment of Toxic Epidermal Necrolysis
Condition: Stevens - Johnson Syndrome
Interventions: Drug: recombinant granulocyte - colony stimulating factor;   Drug: NaCl 0.9%

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years